Submitted by Anonymous (not verified) on 16 October 2023 - 15:17
Human medicines European public assessment report (EPAR): Zimbus Breezhaler, indacaterol,glycopyrronium,mometasone furoate, Asthma, Date of authorisation: 03/07/2020, Revision: 4, Status: Authorised
Source: